| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMD) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. RVMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $381.21M | - | |
| Other | 278.6K | $45.41M | - | |
| Other | 232.5K | $37.89M | - | |
| COO | 119.9K | $19.54M | - | |
| ? | 96.6K | $15.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | Horn Margaret A48 | Chief Operating Officer | Sell | 4,331 | $44.19 | $191,366.53 | -3.2% | +0.4% | +0.4% | |
| Sep 16, 2024 | Kelsey Stephen Michael46 | See Remarks | Sell | 4,665 | $44.19 | $206,124.42 | -1.7% | +0.4% | +0.4% | |
| Sep 16, 2024 | Cislini Jeff | General Counsel | Sell | 1,454 | $44.19 | $64,245.43 | -3.1% | +0.4% | +0.4% | |
| Sep 13, 2024 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 16,667 | $43.32 | $722,087.47 | -2.9% | +2.8% | +6.5% | |
| Aug 13, 2024 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 16,667 | $42.98 | $716,389.33 | -5.8% | +40.9% | -16.1% | |
| Aug 1, 2024 | Goldsmith Mark A52 | See Remarks | Sale+OE | 10,000 | $45.88 | $458,826.92 | -1.6% | +11.6% | -19.1% | |
| Jul 15, 2024 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 16,667 | $46.47 | $774,516.46 | -1.2% | +7.0% | -17.8% | |
| Jul 12, 2024 | Goldsmith Mark A52 | See Remarks | Sale+OE | 35,000 | $45.04 | $1,576,322.00 | -8.8% | +9.7% | -15.8% | |
| Jul 9, 2024 | Patel Sushil66 | Director | Sale+OE | 2,155 | $44.00 | $94,820.00 | -9.7% | +7.8% | -12.3% | |
| Jul 9, 2024 | Cislini Jeff | General Counsel | Sell | 2,399 | $40.83 | $97,951.17 | -4.8% | +7.8% | -12.3% |